BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35102273)

  • 1. Targeting mAKAPβ expression as a therapeutic approach for ischemic cardiomyopathy.
    Martinez EC; Li J; Ataam JA; Tokarski K; Thakur H; Karakikes I; Dodge-Kafka K; Kapiloff MS
    Gene Ther; 2023 Aug; 30(7-8):543-551. PubMed ID: 35102273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
    Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
    Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signalosome-Regulated Serum Response Factor Phosphorylation Determining Myocyte Growth in Width Versus Length as a Therapeutic Target for Heart Failure.
    Li J; Tan Y; Passariello CL; Martinez EC; Kritzer MD; Li X; Li X; Li Y; Yu Q; Ohgi K; Thakur H; MacArthur JW; Ivey JR; Woo YJ; Emter CA; Dodge-Kafka K; Rosenfeld MG; Kapiloff MS
    Circulation; 2020 Dec; 142(22):2138-2154. PubMed ID: 32933333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein phosphatase 2A anchoring disruptor gene therapy for familial dilated cardiomyopathy.
    Li X; Li J; Samuelsson AM; Thakur H; Kapiloff MS
    Mol Ther Methods Clin Dev; 2024 Jun; 32(2):101233. PubMed ID: 38572067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of cardiomyocyte-selective adeno-associated virus serotype 9 vectors in swine following intracoronary and intravenous infusion.
    Li J; Kelly SC; Ivey JR; Thorne PK; Yamada KP; Aikawa T; Mazurek R; Turk JR; Silva KAS; Amin AR; Tharp DL; Mueller CM; Thakur H; Leary EV; Domeier TL; Rector RS; Fish K; Cividini F; Ishikawa K; Emter CA; Kapiloff MS
    Physiol Genomics; 2022 Jul; 54(7):261-272. PubMed ID: 35648460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mAKAPβ signalosome: A potential target for cardiac hypertrophy.
    Golatkar V; Bhatt LK
    Drug Dev Res; 2023 Sep; 84(6):1072-1084. PubMed ID: 37203301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
    Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
    Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bidirectional regulation of HDAC5 by mAKAPβ signalosomes in cardiac myocytes.
    Dodge-Kafka KL; Gildart M; Li J; Thakur H; Kapiloff MS
    J Mol Cell Cardiol; 2018 May; 118():13-25. PubMed ID: 29522762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of mAKAPβ in the process of cardiomyocyte hypertrophy induced by angiotensin II.
    Guo H; Liu B; Hou L; The E; Li G; Wang D; Jie Q; Che W; Wei Y
    Int J Mol Med; 2015 May; 35(5):1159-68. PubMed ID: 25739102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyocyte-specific deletion of Gsk3α mitigates post-myocardial infarction remodeling, contractile dysfunction, and heart failure.
    Ahmad F; Lal H; Zhou J; Vagnozzi RJ; Yu JE; Shang X; Woodgett JR; Gao E; Force T
    J Am Coll Cardiol; 2014 Aug; 64(7):696-706. PubMed ID: 25125302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient Cell Cycle Induction in Cardiomyocytes to Treat Subacute Ischemic Heart Failure.
    Abouleisa RRE; Salama ABM; Ou Q; Tang XL; Solanki M; Guo Y; Nong Y; McNally L; Lorkiewicz PK; Kassem KM; Ahern BM; Choudhary K; Thomas R; Huang Y; Juhardeen HR; Siddique A; Ifthikar Z; Hammad SK; Elbaz AS; Ivey KN; Conklin DJ; Satin J; Hill BG; Srivastava D; Bolli R; Mohamed TMA
    Circulation; 2022 Apr; 145(17):1339-1355. PubMed ID: 35061545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure-inducible gene therapy targeting protein phosphatase 1 prevents progressive left ventricular remodeling.
    Miyazaki Y; Ikeda Y; Shiraishi K; Fujimoto SN; Aoyama H; Yoshimura K; Inui M; Hoshijima M; Kasahara H; Aoki H; Matsuzaki M
    PLoS One; 2012; 7(4):e35875. PubMed ID: 22558250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mAKAPβ signalosomes - A nodal regulator of gene transcription associated with pathological cardiac remodeling.
    Dodge-Kafka K; Gildart M; Tokarski K; Kapiloff MS
    Cell Signal; 2019 Nov; 63():109357. PubMed ID: 31299211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Therapy With Angiotensin-(1-9) Preserves Left Ventricular Systolic Function After Myocardial Infarction.
    Fattah C; Nather K; McCarroll CS; Hortigon-Vinagre MP; Zamora V; Flores-Munoz M; McArthur L; Zentilin L; Giacca M; Touyz RM; Smith GL; Loughrey CM; Nicklin SA
    J Am Coll Cardiol; 2016 Dec; 68(24):2652-2666. PubMed ID: 27978950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure.
    Karam S; Margaria JP; Bourcier A; Mika D; Varin A; Bedioune I; Lindner M; Bouadjel K; Dessillons M; Gaudin F; Lefebvre F; Mateo P; Lechène P; Gomez S; Domergue V; Robert P; Coquard C; Algalarrondo V; Samuel JL; Michel JB; Charpentier F; Ghigo A; Hirsch E; Fischmeister R; Leroy J; Vandecasteele G
    Circulation; 2020 Jul; 142(2):161-174. PubMed ID: 32264695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiomyocyte Krüppel-Like Factor 5 Promotes De Novo Ceramide Biosynthesis and Contributes to Eccentric Remodeling in Ischemic Cardiomyopathy.
    Hoffman M; Palioura D; Kyriazis ID; Cimini M; Badolia R; Rajan S; Gao E; Nikolaidis N; Schulze PC; Goldberg IJ; Kishore R; Yang VW; Bannister TD; Bialkowska AB; Selzman CH; Drakos SG; Drosatos K
    Circulation; 2021 Mar; 143(11):1139-1156. PubMed ID: 33430631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTO-Dependent N
    Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
    Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of Epigenetically Modified Adult Cardiac c-Kit+ Cells Retards Remodeling and Improves Cardiac Function in Ischemic Heart Failure Model.
    Zakharova L; Nural-Guvener H; Feehery L; Popovic-Sljukic S; Gaballa MA
    Stem Cells Transl Med; 2015 Sep; 4(9):1086-96. PubMed ID: 26240433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An adenylyl cyclase-mAKAPbeta signaling complex regulates cAMP levels in cardiac myocytes.
    Kapiloff MS; Piggott LA; Sadana R; Li J; Heredia LA; Henson E; Efendiev R; Dessauer CW
    J Biol Chem; 2009 Aug; 284(35):23540-6. PubMed ID: 19574217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Fas-associated death domain-containing protein (FADD) protects against myocardial ischemia/reperfusion injury in a heart failure mouse model.
    Fan Q; Huang ZM; Boucher M; Shang X; Zuo L; Brinks H; Lau WB; Zhang J; Chuprun JK; Gao E
    PLoS One; 2013; 8(9):e73537. PubMed ID: 24058479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.